| Merri Lynn Carroll, MSN,FNP-C | |
|
868 N Dean Rd Ste C, Auburn, AL 36830-9423 | |
| (334) 209-2550 | |
| (334) 209-2554 |
| Full Name | Merri Lynn Carroll |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 868 N Dean Rd Ste C, Auburn, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255780433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-056781 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The East Alabama Health Care Authority | 3072403237 | 81 |
News Archive
Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, under which Pieris will apply its proprietary Anticalin technology to discover novel Anticalin drugs against multiple targets, with further development undertaken by Sanofi-Aventis and Sanofi-Pasteur. The collaboration will initially involve two targets nominated by Sanofi-Aventis and Sanofi-Pasteur, and includes the option for four additional targets.
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.
Viking Systems, Inc. announced today that it has received clearance of its 510(k) application by the Food and Drug Administration related to its Next Generation 3DHD visualization system. The System is scheduled for market launch in Washington D.C. at this year's American College of Surgeons' Annual Clinical Congress which will be held from October 3-7.
According to a new study published last week in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury (AKI). The study carried out in Vicenza, Italy, tested blood samples collected during admission to the ICU using the Triage® NGAL Test, a product currently sold by Inverness Medical Innovations, Inc. outside of the United States.
The concept that chronic pain is a disease in its own right is leading to new specific treatments aimed at physical, psychological, and environmental components of this major disease, including genetic predisposition, according to a world renowned pain medicine expert.
› Verified 3 days ago
| Entity Name | The East Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073685483 PECOS PAC ID: 3072403237 Enrollment ID: O20040824001092 |
News Archive
Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, under which Pieris will apply its proprietary Anticalin technology to discover novel Anticalin drugs against multiple targets, with further development undertaken by Sanofi-Aventis and Sanofi-Pasteur. The collaboration will initially involve two targets nominated by Sanofi-Aventis and Sanofi-Pasteur, and includes the option for four additional targets.
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.
Viking Systems, Inc. announced today that it has received clearance of its 510(k) application by the Food and Drug Administration related to its Next Generation 3DHD visualization system. The System is scheduled for market launch in Washington D.C. at this year's American College of Surgeons' Annual Clinical Congress which will be held from October 3-7.
According to a new study published last week in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury (AKI). The study carried out in Vicenza, Italy, tested blood samples collected during admission to the ICU using the Triage® NGAL Test, a product currently sold by Inverness Medical Innovations, Inc. outside of the United States.
The concept that chronic pain is a disease in its own right is leading to new specific treatments aimed at physical, psychological, and environmental components of this major disease, including genetic predisposition, according to a world renowned pain medicine expert.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Merri Lynn Carroll, MSN,FNP-C 1649 Highway 22 W, Alexander City, AL 35010-4413 Ph: (256) 215-5323 | Merri Lynn Carroll, MSN,FNP-C 868 N Dean Rd Ste C, Auburn, AL 36830-9423 Ph: (334) 209-2550 |
News Archive
Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, under which Pieris will apply its proprietary Anticalin technology to discover novel Anticalin drugs against multiple targets, with further development undertaken by Sanofi-Aventis and Sanofi-Pasteur. The collaboration will initially involve two targets nominated by Sanofi-Aventis and Sanofi-Pasteur, and includes the option for four additional targets.
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.
Viking Systems, Inc. announced today that it has received clearance of its 510(k) application by the Food and Drug Administration related to its Next Generation 3DHD visualization system. The System is scheduled for market launch in Washington D.C. at this year's American College of Surgeons' Annual Clinical Congress which will be held from October 3-7.
According to a new study published last week in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury (AKI). The study carried out in Vicenza, Italy, tested blood samples collected during admission to the ICU using the Triage® NGAL Test, a product currently sold by Inverness Medical Innovations, Inc. outside of the United States.
The concept that chronic pain is a disease in its own right is leading to new specific treatments aimed at physical, psychological, and environmental components of this major disease, including genetic predisposition, according to a world renowned pain medicine expert.
› Verified 3 days ago
Abby Smith Barnes, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1925 E Glenn Ave, Auburn, AL 36830 Phone: 334-528-0078 Fax: 334-528-0079 | |
Keith Matthews, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2375 Champions Blvd, Auburn, AL 36830 Phone: 334-887-5244 Fax: 334-826-2111 | |
Sarah Elizabeth Kuhlers, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 122 Tichenor Ave, Auburn, AL 36830 Phone: 334-501-3242 | |
Deborah Jackson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2900 E University Dr Ste 110, Auburn, AL 36830 Phone: 334-502-2440 Fax: 334-502-2460 | |
Anaidra L Reese, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2079 S Evergreen Dr, Auburn, AL 36830 Phone: 334-559-5071 | |
Laura Savage Herring, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 986 Drew Ln, Auburn, AL 36830 Phone: 800-678-4611 | |
Joyce Williford, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650a S College St, Auburn, AL 36832 Phone: 334-821-3221 Fax: 334-821-1389 |